SQUAWK/NEWS
Account
Account
Menu
Live NewsCategoriesequity

Biomea Fusion, Inc. (BMEA) News

Track canonical SquawkNews coverage tagged to BMEA, Biomea Fusion, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol BMEA Asset equity Sector Markets 90 days 1 Last 1.285 Updated Aug 13, 2026, 11:00 AM UTC Open live news feed
L Biomea Fusion doses first patient in OPAL obesity study Biomea Fusion says the first patient has been dosed in its OPAL study evaluating icovamenib in combination with semaglutide in obesity. EQUITY | Aug 13, 2026, 11:00 AM UTC